Login / Signup

How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites.

John H HuberCristian KoepfliGuido EspañaNarimane NekkabMichael T WhiteT Alex Perkins
Published in: Malaria journal (2021)
Site-specific biases are likely to contribute to variation in efficacy estimates both within and across clinical trials. Future clinical trials can reduce site-specific biases by conducting trials in low-transmission settings where re-infections from mosquito bite are less common, by preventing re-infections using vector control measures, or by identifying and excluding likely re-infections that occur during follow-up, by using parasite genotyping methods.
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • phase iii
  • study protocol
  • randomized controlled trial
  • dna methylation
  • gene expression
  • dengue virus
  • current status
  • toxoplasma gondii
  • plasmodium falciparum